Safety of COVID-19 Patients and Use of Medicines without Scientific Evidence of Their Benefit, 26 May 2020
MetadataShow full item record
Other Language Versions
COVID-19 treatment options currently under study include several antiviral drugs and immune modulators, the antimalarials chloroquine and hydroxychloroquine, corticosteroids, convalescent plasma, pharmaceutical products that target the renin-angiotensin system, hyperbaric oxygen, and nitric oxide, among many others. However, except for remdesivir, which underwent a clinical trial that showed some preliminary positive results, a systematic review by the Pan American Health Organization has so far failed to identify a treatment option that can effectively address the causative agent of COVID-19. The same can be said with regard to prophylaxis. PAHO and WHO are regularly publishing up-to-date summaries of available evidence on the effectiveness of these interventions.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil Rodrigues Campos, Karoline; Tavares Sacchi, Cláudio; Abbud, Adriano; Caterino-de-Araujo, Adele (2021-09-15)[ABSTRACT]. COVID-19 vaccination began in São Paulo, Brazil in January 2021, first targeting healthcare workers (HCWs) and the elderly, using the CoronaVac vaccine (Sinovac/Butantan) and subsequently the Oxford/AstraZeneca ...
Pan American Health Organization; Health Emergencies (PHE) (Washington, D.C., PAHO, 2021-06-29)SITUATION IN NUMBERS: Region of the Americas 72,186,916 cases; 1,896,954 deaths; 56 countries/areas/territories affected. | Global 181,288,133 cases; 3,933,400 deaths; 236 countries/areas/territories affected.
Pan American Health Organization; Health Emergencies (PHE) (Washington, D.C., PAHO, 2021-06-19)As of 16 June 2021, 176,480,226 confirmed cumulative cases of COVID-19 have been reported globally, including 3,825,240 deaths, for which the Region of the Americas contributed 40% of cases and 48% of deaths. As of 17 June ...